More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.42B
EPS
1.51
P/E ratio
49.1
Price to sales
2.22
Dividend yield
--
Beta
1.167157
Previous close
$69.31
Today's open
$69.72
Day's range
$68.88 - $71.36
52 week range
$45.85 - $79.29
show more
CEO
David H. Li
Employees
1600
Headquarters
North Charleston, SC
Exchange
New York Stock Exchange
Shares outstanding
34377922
Issue type
Common Stock
Materials
Chemicals
Ingevity included in TIME America's Best Companies 2026 list
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity included in TIME America's Best Companies 2026 list.
Business Wire • Aug 18, 2026

NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes
Ingevity's Q2 earnings beat estimates as pricing, mix and higher volumes lifted margins, prompting higher 2026 earnings and EBITDA guidance.
Zacks Investment Research • Aug 6, 2026

Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation has published its 2025 Sustainability Report titled “A Decade of Performance, a Future of Possibility.".
Business Wire • Aug 5, 2026

Ingevity Q2 Earnings Call Highlights
Ingevity NYSE: NGVT reported second-quarter 2026 results marked by higher adjusted earnings, margin expansion and progress on its portfolio simplification efforts, as the company raised its full-year adjusted EBITDA and earnings-per-share outlook.
MarketBeat • Jul 31, 2026

Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Seeking Alpha • Jul 30, 2026

Ingevity reports second quarter 2026 financial results
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year.
Business Wire • Jul 29, 2026

Ingevity (NGVT) Tops Q2 Earnings and Revenue Estimates
Ingevity (NGVT) came out with quarterly earnings of $1.74 per share, beating the Zacks Consensus Estimate of $1.31 per share. This compares to earnings of $1.39 per share a year ago.
Zacks Investment Research • Jul 30, 2026

NGVT's Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use
Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.
Zacks Investment Research • Jul 17, 2026

Ingevity's Evotherm® P35 receives BASt approval in Germany
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt.
Business Wire • Jul 16, 2026

Ingevity Shares Rise 25% YTD: Can the Stock Sustain the Rally?
NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pricing actions drive earnings and boost outlook.
Zacks Investment Research • Jul 7, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Ingevity Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.